Dr. Baxi Hemang Ashwinbhai
MD, DM (Cardiology)

Mobile: 98250 30111

   
NAME Dr. Baxi Hemang Ashwinbhai
SEX Male
PERMANENT ADDRESS

Clinic:
The Heart Care Clinic
2nd Floor, Balleshwar Avenue
Opp. Rajpath Club, S G Highway
Ahmedabad 380 015 (INDIA)
Ph: (079) 26873101 / 26873224 / 26873325
Fax: (079) 26872195

Residence:
A-401, Samay Apartment,
Nr. Azad Society,
Besides Vastrapur Telephone Exchange
Satellite, Ahmedabad 380 015.
Phone: (R) 2674 7703
           (M) 98250 30111

EMAIL hemang.baxi@heartcareclinic.org, drhemangbaxi@rediffmail.com
DATE OF BIRTH 7th January 1969
FORMER AFFILIATIONS AS CARDIOLOGIST
  1. U. N. Mehta Heart Institute, Civil Hospital, Ahmedabad.
  2. Rajasthan Hospital, Ahmedabad.
  3. Consultant and Interventional Cardiologist, SAL Hospital, Ahmedabad.
  4. Sheth V.S.General Hospital, Ahmedabad
PRESENT AFFILIATIONS AS CARDIOLOGIST

Sterling Hospital, Ahmedabad
Apollo Hospital, Ahmedabad
Krishna Heart Institute, Ahmedabad

EDUCATION

 

Schooling: St. Xavier High School, Gandhinagar, Gujarat.
Stood 8th in SSC Board, Gujarat.

Medical:    B. J. Medical College, Civil Hospital, Ahmedabad

Board (Degree)Bachelor of Medicine & Surgery (MBBS) 1992
                         Doctor of Medicine (MD) (Gen. Medicine) 1995
                         Doctor of Medicine (DM) (Cardiology) 1998 Gold Medalist

Fellowship Residency:

  • Internship: July 1991-June 1992
    Civil Hospital, Ahmedabad.
  • Residency in Internal Medicine: July 1992- June 1995
    Civil Hospital, Ahmedabad.
  • Research Fellow at U N Mehta Cardiology Institute
    Civil Hospital, Ahmedabad: July 1995 – Dec 1995
  • Residency in Cardiology: January 1996-April 1998
    U N Mehta Heart Hospital, Ahmedabad.
  • Research Fellow at U N Mehta Heart Hospital,
    Ahmedabad: April 1998- September 1998

LICENSURE

Gujarat Medical Council: G-20576

PROFESSIONAL MEMBERSHIP

Life Member of Cardiac Society of India

PROFESSIONAL EXPERIENCE

Interventional Cardiologist

  • Rajasthan Hospital : Oct 1998 to Sept 2001
  • Sterling Hospital:  Oct 2001 to Feb 2004
  • S. A. L Hospital : March 2004 onwards

CARDIAC INTERVENTIONS

Over 5000 Cardiac Catheterizations including complex
Coronary angiograms, valvular diseases, grafts, etc.
Over 1000 PTCA /Angioplasties including complex Multivessel grafts, etc.
Over 200 cases in Primary/Rescue Angioplasties
Over 800 stents used.
Over 500 Balloon Mitral Valvuloplasties
Over 50 Other valvular interventions

PERIPHERAL INTERVENTIONS

Over 100 cases of Peripheral Interventions       
Over 200 cases of Peripheral Diagnostic Angiography
Over 50 Percutaneous Intra vascular Stenting.
Over 50 Pacemaker implantation

           

RESEARCH WORK AND PUBLI

  1. Left main coronary artery disease in Gujarati population. Dr. Sameer Dani, Dr. Anish Chandarana, Dr. Jayesh Rawal, Dr. Bhupesh Shah, Dr. Urmil Shah, Dr. Sharad Jain, Dr. Hemang Baxi, Dr. Hasit Joshi.
  1. Pulmonary Stenosis: Long term results of balloon dilatation. Dr. Sameer Dani, Dr. Jayesh Rawal, Dr. Bhupesh Shah, Dr. Sharad Jain, Dr. Urmil Shah, Dr. Hemang Baxi, Dr. Anish Chandarana, Dr. Hasit Joshi.
  1. Combination of plain PTCA with stenting in coronary artery disease: immediate and intermediate-term outcome. Dr. S. I. Dani, Dr. B.R. Shah, Dr. U.G. Shah, Dr. H. Baxi, Dr. A. Chandarana, Dr. H. Joshi.
  1. Intracoronary Saint Come stents: Short and mid-term follow up results. Dr. B.R. Shah, Dr. S.I. Dani, Dr. U.G. Shah, Dr. S. R. Jain, Dr. A. Chandarana, Dr. H. Baxi.
  1. Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik AM, Goyal R.K. Effect of Folate Treatment on Homocysteinemia in Cardiac Patients: A Prospective Study: Indian J Pharmacol. (Abstract)
  1. Parikh K.H., Chag M.C, Shah U.G, Baxi H.A., Chandarana A.H., Naik A.M, Goyal R.K., Shah K.J. Acute results and Intermediate term follow up of PCI with Cardioprotection by Balloon Occlusion Distal Protection Device. Indian Heart J. J-233, 2002; 54: 561-568.
  1. Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of Folate Treatment on Pharmacological Homocysteinemia in Cardiac Research Patients: A Prospective Study. Pharmacological Research (submitted) 2003.
  1. Mehta K.N., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of Folate Treatment on Homocysteinemia in Patients: A Prospective Study. Indian J Cardiol.2003; 5: 53
  1. Shah K.J., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Reversal of Slow-Flow or No-Reflow in PTCA using boluses of IC Adenosine and Sodium Nitroprusside combination. Indian J Cardiol. 2003: 5: 38.
  1. Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M.,Shah K.J., Goyal R.K. Reversal of Slow-Flow or No-Reflow in PTCA using Boluses of IC Adenosine and Sodium Nitroprusside. Suppl to JACC, March 19, 2003; 41 (6), Suppl A: 1101- 201
  1. Shah K.J., Parikh K.H., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Prevalence of hyperhomocysteinemia in Western Indian Population with or without Coronary Artery Disease. Indian J Cardiol. (In Press).
  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. (Accepted for Poster Presentation) Annual conference of Society of Cardiovascular Angiography and Interventions (SCAI) 2004
  1. Chag M.C., Shah H. D., Parikh K.H., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Increased Lipoprotein (a) as a strong risk factor for Coronary Artery Disease and the effect of Niacin amongst Indians. European Society of  Cardiology (Submitted) 2004.
  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Beneficial effects of Distal Protection device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions. European Society of  Cardiology (Submitted) 2004.
  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Improvement in MACE by sequential administration of boluses of Intracoronary Adenosine and Sodium Nitroprusside during Percutaneous Coronary Interventions. European Society of  Cardiology (Submitted) 2004.
  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Revascularization in Acute Myocardial Infarction using PercuSurge in Distal Protection. European Society of  Cardiology (Submitted) 2004.
  1. Parikh K.H., Shah H. D., Chag M.C., Shah U.G., Baxi H.A., Chandarana A.H., Naik A.M., Goyal R.K. Effect of combination of statins and fenofibrate with acute coronary syndrome undergoing Percutaneous Coronary Interventions. European Society of  Cardiology (Submitted) 2004.
CLINICAL RESEARCH ACCOMPLISHED
  1. Effect of Folate treatment on Homocysteinemia in cardiac patients: A Prospective Study.
  1. Pharmacoepidemiology and Risk factors of Hypertension in Gujarat.

  2. Reversal of slow or no- reflow During Percutaneous Transluminal Coronary Angioplasty Using Boluses of Intracoronary Adenosine and Sodium Nitroprusside in combination.
  1. Acute Results of Intermediate – term follow up of Percutaneous Transluminal Coronary Angioplasty with Cardioprotection by Balloon Occlusion Distal Protection Device.

  2. Effect of Tirofiban HCl in Patients with Acute Coronary Syndrome and its comparison with other GPIIb/IIIa antagonists such as Abciximab and Eptifibatide - A Registry by Zydus Cadila.
  1. Revascularization Utilizing Balloon Protection in Acute Coronary ischemic Syndrome- An International Registry by Medtronic India Ltd.

  2. An International Registry of CYPHER TM-Sirolimus eluting stent by Cordis, Johnson and Johnson.
  1. High prevalence of Renal Artery Stenosis in Hypertensive patients with Triple vessel Coronary Artery Disease.
  1. Effects of Combination of Statins and Fenofibrates with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention.
  1. Effect of Pioglitazone and its combination with Statins in Coronary Artery Disease patients with Hsyperinsulinemia.
  1. Comparison of Drug eluting stent with S7 stent.
  1. Assessment of Risk factors for Coronary Artery Disease.
  1. Effect of Niacin treatment on hyperlipoproteinemia in Coronary Artery Disease patients.
  1. Beneficial effects of Distal Protection Device in reducing the use of Intracoronary Vasodialators and Glycoprotein IIb/IIIa receptor antagonists during Percutaneous Coronary Interventions.
  1. Comparison of Total Procedural time involved in Primary PCI with or without the use of Distal Balloon Protection system in Thrombotic Coronary lesions. (RAPID trial- Revascularization in Acute myocardial infarction using Percusurge In Distal protection
INTERNATIONAL CLINICAL TRIALS
  1. LMWH   in Acute Coronary Syndrome.
  1. LMWH in Acute Myocardial Infarction.
  1. Angiotensin Receptor Blocker in  Paediatric  Hypertension.
  1. Prostacyclin Analogue in Pulmonary Hypertension.

  2. Newer generation statin in   Hyperlipidemia.
  1. Coronary Sinus stent   like device   for retroperfusion in Coronary Artery Disease.
  1. Implantable Ultrasonic device for PA pressure measurement in Heart failure.
TOP  
 
 
   © Copyright 2010 The Heart Care Clinic